Medical - Pharmaceuticals industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.
Ranked among 5 stocks with a market cap above $500M. Smaller companies are excluded from the ranking.
Rank | Company | Price | P/E | Value | Growth | Quality | EL7 Score |
|---|---|---|---|---|---|---|---|
| 1/5 |  | $76.27 | 75.5 | 12 | 95 | 95 | 98 |
| 2/5 |  | $58.61 | 40.0 | 30 | 37 | 92 | 77 |
| 3/5 |  | $112.79 | 268.5 | 5 | 47 | 87 | 68 |
| 4/5 |  | $66.74 | 47.7 | 19 | 100 | 97 | 40 |
| 5/5 |  | $12.97 | — | 23 | 72 | 21 | 38 |
| — |  | $22.15 | — | — | — | — | — |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
32 of 151
P/E 47.7 vs period average 29.9 Richer than its history
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Insider purchases in the sector's stocks
Funds that track the sector and each fund's exposure to it.
Fund | Exposure | Assets | Expense |
|---|---|---|---|
| IBBiShares Biotechnology ETF | 100.0% | $10B | 0.44% |
| VHTVanguard Health Care ETF | 100.0% | $21B | 0.09% |
| IHIiShares U.S. Medical Devices ETF | 99.7% | $3B | 0.37% |
| XLVState Street Health Care Select Sector SPDR ETF | 99.2% | $43B | 0.08% |
The percentage is the sector's share of the fund's assets, per the latest available data.
Upgrades and downgrades on the sector's stocks
